According to the latest report by IMARC Group, titled "Kidney/Renal Function Test Market Report by Test Type (Urine Tests, Blood Tests), Product (Dipsticks, Reagents, Disposables), End Use (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, and Others), and Region 2025-2033," the global kidney/renal function test market size reached USD 932.7 Million in 2024. A kidney/renal function test is generally suggested by healthcare professionals for analyzing and diagnosing problems in the overall functioning of the kidney. It involves collecting urine and blood samples in order to determine the glomerular filtration rate (GFR) and the presence of albumin in the urine for assessing the filtration function. It is widely adopted to determine appropriate patient management while monitoring the progression of diseases and preventing the further deterioration of renal function. Some of the common kidney-related diseases include cystinosis, glomerulonephritis, IgA nephropathy, lupus nephritis, atypical hemolytic uremic syndrome (aHUS) and polycystic kidney disease (PKD).
Global Kidney/Renal Function Test Market Trends:
The global market is primarily driven by the increasing prevalence of chronic kidney diseases (CKD) among the masses. This is attributed to the escalating rate of individuals suffering from diabetes and hypertension due to the sedentary lifestyle led by the masses and the growing geriatric population. In line with this, the sudden outbreak of coronavirus disease (COVID-19) has significantly supported the demand for kidney/renal function tests across the globe. This is due to the widespread occurrence of acute kidney infection (AKI) among the infected patients, generally caused due to inflammation of the kidneys. Along with this, the rising spending by key players for conducting extensive research and development (R&D) activities in order to introduce improved testing devices is creating a positive market outlook. In line with this, continual technological advancements in the testing process resulting in the early diagnosis of diseases are impacting the market growth favorably. Looking forward, the market value is projected to reach USD 1,729.2 Million by 2033, expanding at a CAGR of 6.6% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Test Type, Product, End Use, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 77 Elektronika Kft., Abbott Laboratories, Acon Laboratories, Inc., Arkray, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Nova Biomedical, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Siemens Healthcare GmbH, and Sysmex Corporation |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800